M&A Deal Summary

Edgecap Partners Acquires Comac Medical

On June 9, 2023, family office Edgecap Partners acquired life science company Comac Medical

Acquisition Highlights
  • This is Edgecap Partners’ 1st transaction in the Life Science sector.
  • This is Edgecap Partners’ 1st transaction in Bulgaria.

M&A Deal Summary

Date 2023-06-09
Target Comac Medical
Sector Life Science
Buyer(s) Edgecap Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Comac Medical

Sofia, Bulgaria
Comac Medical is a full-service clinical research organization (CRO) in South-Eastern Europe, present in more than 30 countries, providing a comprehensive range of early to late-phase drug development services to the global pharmaceutical and biotech industries across a variety of therapeutic areas with a differentiated expertise and track record for indications within oncology, dermatology, gastroenterology, and respiratory diseases. The Company has a global customer base consisting of emerging biotech and established pharmaceutical companies, offering full outsourced clinical trial support across the entire clinical development timeline. Comac Medical was formed in 1997 and is based in Sofia, Bulgaria.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

DESCRIPTION


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Buyout (LBO, MBO, MBI)) 1 of 1
Country (Bulgaria) 1 of 1
Year (2023) 1 of 1